Effects of Rome IV Definitions of Functional Dyspepsia Subgroups in Secondary Care.

Dyspeptic Patients Gastroduodenal Questionnaire Overlapping PDS-EPS Postprandial Burning Postprandial Pain “Adapted” PDS Group

Journal

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
ISSN: 1542-7714
Titre abrégé: Clin Gastroenterol Hepatol
Pays: United States
ID NLM: 101160775

Informations de publication

Date de publication:
08 2021
Historique:
received: 29 01 2020
revised: 18 05 2020
accepted: 17 06 2020
pubmed: 10 7 2020
medline: 10 9 2021
entrez: 10 7 2020
Statut: ppublish

Résumé

Functional dyspepsia (FD) is subdivided into postprandial distress syndrome (PDS) and epigastric pain syndrome (EPS) according to the Rome III consensus. In clinical practice, there is a major overlap between these subgroups. The Rome IV criteria included postprandially occurring symptoms in the PDS subgroup. We aimed to analyze the effects of the Rome IV criteria, compared with Rome III, on FD subgroups in patients recruited from secondary care. Patients with FD (n = 224; mean age, 43 ± 1 y; 77% women) were recruited from secondary-care units in Belgium and filled out symptom questionnaires, allowing subdivision according to Rome III and Rome IV criteria and identification of postprandial symptoms. Symptom patterns and demographics were compared between the subgroups. Statistical analysis was performed using the t test and the Fisher exact test. According to the Rome III criteria, 25% of participants had PDS, 8% had EPS, and 67% had an overlap. Postprandial fullness, early satiation, and bloating were present in significantly more patients in the PDS and overlap groups than the EPS group (P < .0001). A higher proportion of patients in the overlap group showed symptoms such as postprandial epigastric pain and nausea than in the EPS group (both P ≤ .02). With the Rome IV criteria, the overlap group was reduced to 35%; 57% of patients were considered to have PDS and 8% to have EPS. Postprandial pain was significantly more prevalent in the PDS than in the EPS group (P ≤ .002), and postprandial nausea was significantly more prevalent in the PDS group than the overlap group (P = .007). Compared with Rome III criteria, the Rome IV criteria significantly reduces the overlap between PDS and EPS groups. Studies are needed to determine if Rome IV subgroups are associated differently with psychological comorbidities and treatment responses.

Sections du résumé

BACKGROUND & AIMS
Functional dyspepsia (FD) is subdivided into postprandial distress syndrome (PDS) and epigastric pain syndrome (EPS) according to the Rome III consensus. In clinical practice, there is a major overlap between these subgroups. The Rome IV criteria included postprandially occurring symptoms in the PDS subgroup. We aimed to analyze the effects of the Rome IV criteria, compared with Rome III, on FD subgroups in patients recruited from secondary care.
METHODS
Patients with FD (n = 224; mean age, 43 ± 1 y; 77% women) were recruited from secondary-care units in Belgium and filled out symptom questionnaires, allowing subdivision according to Rome III and Rome IV criteria and identification of postprandial symptoms. Symptom patterns and demographics were compared between the subgroups. Statistical analysis was performed using the t test and the Fisher exact test.
RESULTS
According to the Rome III criteria, 25% of participants had PDS, 8% had EPS, and 67% had an overlap. Postprandial fullness, early satiation, and bloating were present in significantly more patients in the PDS and overlap groups than the EPS group (P < .0001). A higher proportion of patients in the overlap group showed symptoms such as postprandial epigastric pain and nausea than in the EPS group (both P ≤ .02). With the Rome IV criteria, the overlap group was reduced to 35%; 57% of patients were considered to have PDS and 8% to have EPS. Postprandial pain was significantly more prevalent in the PDS than in the EPS group (P ≤ .002), and postprandial nausea was significantly more prevalent in the PDS group than the overlap group (P = .007).
CONCLUSIONS
Compared with Rome III criteria, the Rome IV criteria significantly reduces the overlap between PDS and EPS groups. Studies are needed to determine if Rome IV subgroups are associated differently with psychological comorbidities and treatment responses.

Identifiants

pubmed: 32645450
pii: S1542-3565(20)30906-X
doi: 10.1016/j.cgh.2020.06.043
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1620-1626

Informations de copyright

Copyright © 2021 AGA Institute. Published by Elsevier Inc. All rights reserved.

Auteurs

Karen Van den Houte (K)

Translational Research Center for Gastrointestinal Diseases, University of Leuven, Leuven, Belgium.

Florencia Carbone (F)

Translational Research Center for Gastrointestinal Diseases, University of Leuven, Leuven, Belgium.

Nick Goelen (N)

Translational Research Center for Gastrointestinal Diseases, University of Leuven, Leuven, Belgium.

Jolien Schol (J)

Translational Research Center for Gastrointestinal Diseases, University of Leuven, Leuven, Belgium.

Imke Masuy (I)

Translational Research Center for Gastrointestinal Diseases, University of Leuven, Leuven, Belgium.

Joris Arts (J)

Maagdarm en Leverziekten, Algemeen Ziekenhuis Sint Lucas, Brugge, Belgium.

Philip Caenepeel (P)

Ziekenhuis Oost-Limburg, Genk, Belgium.

Dirk Staessen (D)

Sint Vincentius Ziekenhuis, Antwerpen, Belgium.

Philippe Vergauwe (P)

Dienst Gastro Enterologie, Algemeen Ziekenhuis Groeninge, Kortrijk, Belgium.

Guy Van Roey (G)

Department of Gastroenterology, Sint Elisabeth Ziekenhuis, Turnhout, Belgium.

Pascale Latour (P)

Department of Gastroenterology, Centre hospitalier universitaire of Liege, Liege, Belgium.

Hubert Piessevaux (H)

Department of Gastroenterology and Hepatology, Cliniques Universitaires St-Luc, Brussels, Belgium.

Philippe Maldague (P)

Clinique Saint Luc, Service de Gastro-entérologie, Bouge, Belgium.

Ariane Gerkens (A)

Boitsfort Medical Center, Brussels, Belgium.

Fabien Wuestenberghs (F)

Department of Gastroenterology and Hepatology, CHU UCL Namur, Godinne University Hospital, UC Louvain, Yvoir, Belgium.

Alain Vandenberghe (A)

Medical Research Consultant, BVBA, Chaumont-Gistoux, Belgium.

Jan Tack (J)

Translational Research Center for Gastrointestinal Diseases, University of Leuven, Leuven, Belgium. Electronic address: jan.tack@kuleuven.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH